Rhogam administration applies to you only if your blood type is negative. Fifteen percent of Caucasians, 5-8% of African Americans, and 1-2% of Asians and Native Americans are Rh-negative, meaning that they lack a particular molecule on the outside of their red blood cells.
If a woman is carrying a baby who is Rh-positive, like their father, and the woman is Rh-negative, she can react to the baby’s cells. Without knowing the father's blood type, an Rh-negative woman has about a 60% chance of bearing an Rh-positive baby, but less than a 12% chance of becoming sensitized.
Sensitization involves a woman's body making antibodies against what it perceives as foreign, in this case, sugar molecules on the outside of her growing baby's red blood cells. These antibodies can destroy your baby's red blood cells or cause a miscarriage due to severe fetal anemia. These antibodies can also cause problems with future pregnancies.
Rhogam is Rh-immune globulin and is administered as a shot like a vaccine. It prevents most Rh-negative women from developing antibodies to their baby's Rh-positive red blood cells.
If the father of your baby is Rh-negative, you do not need Rhogam at 28 weeks. If you are Rh-negative and the father of your baby is Rh-positive, you must receive Rhogam to protect your future pregnancies. The shot is given at around 28 weeks, and again after your delivery IF your baby is Rh-positive.